Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France

Use of Infliximab in Particular Clinical Settings: Management Based on Current Evidence

(2009) Alfredo Papa et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Spondyloarthropathy and chronic B hepatitis. Effect of anti-TNF therapy

(2009) Daniel Wendling et al.   JOINT BONE SPINE

Use of Tumor Necrosis Factor- -blocking Agents in Hepatitis B Virus-positive Patients: Reports of 3 Cases and Review of the Literature

(2009) S. ZINGARELLI et al.   JOURNAL OF RHEUMATOLOGY

Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression

(2008) L. PEYRIN-BIROULET et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study

(2008) Carme Loras et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Reactivation of hepatitis B in a patient with Crohn’s disease treated using infliximab

(2008) Keisuke Ojiro et al.   JOURNAL OF GASTROENTEROLOGY

Statements from the Taormina expert meeting on occult hepatitis B virus infection

(2008) Giovanni Raimondo et al.   JOURNAL OF HEPATOLOGY

Cyclophilin A Is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine Resistance In Vitro

(2008) F. Yang et al.   JOURNAL OF VIROLOGY

Association of MTRR 66A>G Polymorphism With Superoxide Dismutase and Disease Activity in Patients With Crohn's Disease

(2007) Laurent Peyrin-Biroulet et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY